Core Viewpoint - The company Xinhecheng (002001) is experiencing a decline in stock price despite a general market uptrend, raising concerns among investors about its operational status and upcoming financial disclosures [1][2]. Group 1: Stock Performance - As of October 28, 2025, Xinhecheng's stock closed at 23.36 yuan, down 0.64%, with a turnover rate of 0.8%, trading volume of 243,100 shares, and a transaction value of 569 million yuan [1]. - On the same day, there was a net inflow of 65.66 million yuan from major funds, indicating significant accumulation activity [3]. Group 2: Investor Communication - The company confirmed that its production and operations are normal, and the third-quarter earnings report is scheduled for release on October 29, 2025 [2]. - The company is open to external collaborations and evaluates each investment opportunity based on actual conditions, as evidenced by its joint ventures with DSM and Sinopec in specific sectors [2].

格隆汇10月28日丨新和成(002001.SZ)发布公告，2025年前三季度，实现营业收入166.42亿元，同比增加 5.45%；归属于上市公司股东的净利润53.21亿元，同比增加33.37%；归属于上市公司股东的扣除非经常 性损益的净利润53.33亿元，同比增加37.37%；基本每股收益1.73元。 ...

北京商报讯（记者 丁宁）10月28日晚间，新和成（002001）发布2025年三季报显示，公司前三季度实 现营业收入166.42亿元，同比增长5.45%；归属净利润53.21亿元，同比增长33.37%。 ...

Investment Rating - The industry investment rating is "Outperform the Market" [1] Core Insights - The report emphasizes the significance of the "14th Five-Year Plan" in guiding the development of the chemical industry, focusing on modernizing the economic system, enhancing technological self-reliance, and promoting green transformation [1][2] - It highlights the need for a robust domestic market and the importance of integrating new demand with supply to foster economic growth [2] - The report anticipates that the chemical industry will maintain its competitive position globally, with an expected increase in domestic demand and a reduction in "involution" competition [2][3] Summary by Sections Industry Development - The "14th Five-Year Plan" prioritizes building a modern industrial system and enhancing the competitiveness of traditional industries like chemicals [2] - It calls for the development of strategic emerging industries such as new energy and new materials, alongside the promotion of large-scale applications of new technologies [2] Technological Innovation - The report stresses the importance of high-level technological self-reliance and innovation, aiming for breakthroughs in key areas like integrated circuits and high-end instruments [2][3] Market Dynamics - The report indicates that domestic demand is expected to expand, which will positively impact the chemical industry's global standing [2] - It also mentions the need to eliminate barriers to market entry and improve the overall market environment [2] Green Transformation - The report outlines goals for carbon neutrality and efficient energy use, which will drive industry restructuring and favor leading enterprises [2][3] Investment Recommendations - The report suggests a mid-to-long-term investment strategy focusing on companies that are likely to benefit from policy support and demand recovery, particularly in sectors like semiconductor materials and new energy materials [3] - Specific companies recommended for investment include Wanhua Chemical, Hualu Hengsheng, and others, while companies like Yangnong Chemical and Tongcheng New Materials are suggested for attention [3]

一、会议以 11 票同意，0 票反对，0 票弃权审议通过《2025 年第三季度报 告》；《2025 年第三季度报告》中的财务信息在提交董事会审议前已经公司审计 委员会审议通过。 证券代码：002001 证券简称：新和成 公告编号：2025-047 浙江新和成股份有限公司 第九届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江新和成股份有限公司（以下简称"公司"）第九届董事会第十五次会议 于 2025 年 10 月 23 日以电子邮件方式发出会议通知，于 2025 年 10 月 28 日以现 场结合通讯表决方式召开。应参加表决董事十一名，实际参加表决董事十一名。 公司监事和高级管理人员列席了会议。符合《公司法》和《公司章程》的规定。 会议经表决形成决议如下： 《2025 年第三季度报告》全文详见公司同日在指定信息披露媒体及巨潮资 讯网（http://www.cninfo.com.cn）刊登的公告。 二、会议以 10 票同意，0 票反对，0 票弃权审议通过《关于 2025 年度日常 关联交易调整的议案》，关联董事王正江回避表决；该议 ...

Group 1 - The company Xinhecheng (SZ 002001) announced on October 28 that its 15th meeting of the 9th board of directors was held, discussing the adjustment of related party transactions for the year 2025 [1] - For the first half of 2025, Xinhecheng's revenue composition is 90.23% from pharmaceutical chemicals and 9.77% from other industries [1] - As of the report date, Xinhecheng's market capitalization is 71.8 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after ten years of stagnation, with technology leading the market's transformation [1] - A new "slow bull" market pattern is emerging, indicating a shift in market dynamics [1]

Group 1 - Company Xinhecheng reported Q3 performance with revenue of approximately 16.642 billion yuan, an increase of 5.45% year-on-year [1] - The net profit attributable to shareholders was about 5.321 billion yuan, reflecting a year-on-year increase of 33.37% [1] - Basic earnings per share reached 1.73 yuan, up 34.11% compared to the previous year [1] Group 2 - As of the report, Xinhecheng's market capitalization stands at 71.8 billion yuan [2]

新和成公告，第三季度营收为55.41亿元，下降6.66%；净利润为17.17亿元，下降3.80%。前三季度营收 为166.42亿元，同比增长5.45%；净利润为53.21亿元，同比增长33.37%。 ...

证券代码：002001 证券简称：新和成 公告编号：2025-049 | 关联交易类别 | 关联人 | 关联交易内容 | 年原 2025 | 年现 2025 | 年 2025 | 1-9 | | --- | --- | --- | --- | --- | --- | --- | | | | | 预计金额 | 预计金额 | 月发生金额 | | | 采购货物/接受 | 宁波镇海炼化新和成 | 购买商品、接受 | 17,500 | 32,000 | | 5,362 | | 劳务 | 生物科技有限公司 | 劳务 | | | | | 2、2025 年度其他日常关联交易预计不做调整： 浙江新和成股份有限公司 关于 2025 年度日常关联交易预计调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江新和成股份有限公司（以下简称"公司"）于 2025 年 10 月 28 日召开 的第九届董事会第十五次会议审议通过《关于 2025 年度日常关联交易预计调整 的议案》，关联董事王正江进行了回避表决。根据《深圳证券交易所股票上市规 则》《公司章程》及《关联交易决策制度》等 ...

Financial Performance - Q3 2025 revenue was CNY 5,541,468,928.14, a decrease of 6.66% year-over-year, while year-to-date revenue increased by 5.45% to CNY 16,642,101,764.92[5] - Net profit attributable to shareholders for Q3 2025 was CNY 1,717,397,711.55, down 3.80% year-over-year, but year-to-date net profit rose by 33.37% to CNY 5,320,721,690.71[5] - Basic earnings per share for Q3 2025 was CNY 0.56, a decrease of 3.45% year-over-year, while year-to-date earnings per share increased by 34.11% to CNY 1.73[5] - Total revenue for the current period reached 16,642,101,764.92 RMB, up from 15,781,739,446.23 RMB in the previous period, reflecting a growth of approximately 5.46%[32] - Total operating costs decreased to 10,521,382,709.20 RMB from 11,168,127,903.08 RMB, indicating a reduction of about 5.81%[32] - Operating profit for the current period was 6,252,044,659.79 RMB, compared to 4,775,809,021.33 RMB in the previous period, representing an increase of approximately 30.93%[33] - The total profit for the current period is ¥6,244,262,450.15, an increase from ¥4,773,693,181.03 in the previous period, representing a growth of approximately 30.8%[34] - The net profit attributable to shareholders of the parent company is ¥5,320,721,690.71, up from ¥3,989,518,788.01, reflecting an increase of about 33.4%[34] - Basic and diluted earnings per share increased to ¥1.73 from ¥1.29, marking a rise of approximately 34.3%[35] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 45,093,962,982.74, reflecting a 4.90% increase from the end of the previous year[5] - The company's cash and cash equivalents increased to 8,082,687,914.48 RMB from 7,936,504,805.65 RMB, showing a growth of about 1.85%[27] - Inventory levels rose to 4,514,388,372.66 RMB from 4,090,096,841.96 RMB, reflecting an increase of approximately 10.38%[28] - The total liabilities decreased to 12,737,366,604.64 RMB from 13,543,582,208.04 RMB, indicating a reduction of about 5.95%[30] - The company's retained earnings increased to 24,545,700,558.83 RMB from 21,375,740,194.12 RMB, marking a growth of approximately 14.67%[30] Shareholder Information - Total number of common shareholders at the end of the reporting period was 82,471[19] - New Hecheng Holding Group Co., Ltd. holds 50.08% of shares, totaling 1,539,232,431 shares[19] - The top ten shareholders include various institutional investors, with the largest being New Hecheng Holding Group Co., Ltd.[19] - The company has not disclosed any changes in the participation of major shareholders in margin trading activities[21] Share Repurchase and Dividends - The company plans to repurchase shares with a budget of RMB 300 million to RMB 600 million, with a maximum repurchase price of RMB 31.5 per share[22] - As of September 30, 2025, the company repurchased 14,815,692 shares, accounting for 0.4820% of the total share capital[22] - The maximum repurchase price was adjusted from RMB 32 to RMB 31.5 per share following the annual equity distribution[22] - The company declared a cash dividend of 2 RMB per 10 shares, totaling 611,824,397.60 RMB, with the remaining profits carried forward to the next year[25] Investment and Financing Activities - Non-operating income for Q3 2025 totaled CNY 62,989,738.51, compared to a loss of CNY 12,248,822.89 year-to-date[6] - Investment income increased by 81.63% year-over-year, driven by improved performance from associated enterprises[13] - Cash flow from operating activities for the year-to-date period was CNY 5,642,188,919.25, up 23.28%[5] - The company reported a net investment income of 76,855,004.79 RMB, up from 42,313,966.93 RMB in the previous period, representing an increase of approximately 81.55%[33] - The company intends to issue debt financing tools totaling no more than RMB 3 billion to support rapid development and optimize financing structure[23] - The funds raised from the debt issuance will be used for production activities, including R&D investments and repaying interest-bearing liabilities[23] Cash Flow - Cash flow from operating activities netted ¥5,642,188,919.25, compared to ¥4,576,730,480.43 in the previous period, indicating a growth of around 23.3%[36] - Total cash inflow from investment activities was ¥2,203,384,662.72, significantly higher than ¥243,300,040.95 in the previous period[36] - The net cash flow from financing activities was -¥2,142,708,940.46, worsening from -¥1,256,932,094.80 in the previous period[37] - The cash and cash equivalents at the end of the period amounted to ¥7,424,896,401.24, up from ¥6,843,111,454.61, reflecting an increase of about 8.5%[37] - The company received cash from sales of goods and services totaling ¥16,507,712,441.00, compared to ¥14,208,584,079.52 in the previous period, indicating a growth of approximately 16.1%[35] Comprehensive Income - The total comprehensive income attributable to the parent company was ¥5,299,310,414.65, compared to ¥3,996,948,048.79, showing an increase of approximately 32.6%[35] - The company reported a decrease in other comprehensive income, with a net amount of -¥21,411,276.06 compared to ¥7,429,260.78 in the previous period[34]